Kalm: the semax and selank pairing, examined honestly

A quiet reading corner with a linen chair, open book, and warm lamplight

Kalm is a named combination of semax and selank. Both hold marketing approval in Russia and neither is FDA-approved. No controlled study of the pairing was identified, and neither component is established for cognition or anxiety under U.S. regulatory review.

Composition

  • semax
  • selank

Overview

This is the cleanest example in the cognitive category because it contains only two components, both from the same research tradition. The whole question reduces to how much weight Russian-published research should carry, and whether pairing two substances from that tradition adds anything. On the second question there is no evidence at all.

Why these are grouped

Semax and selank are frequently discussed together in the literature they come from, one framed toward attention and the other toward anxiety. That co-discussion is why the market pairs them. It is not a finding that the pair performs better than either alone.

What each ingredient contributes

semax

Approved in Russia and studied there in attention and neuroprotection contexts. Not FDA-approved.

selank

Approved in Russia and studied there in anxiety contexts. Not FDA-approved.

Combination evidence

  • No controlled study of the semax and selank pairing was identified.
  • No safety data describe the two used together.
  • Frequent co-discussion in the literature is not a combination trial.

Both components have published research and foreign marketing approval. Neither has an FDA review, neither has an adequate contemporary Western replication programme, and neither addresses the pairing.

Preclinical rationale

  • Both are studied for effects on neuropeptide and neurotransmitter signalling, including work on brain-derived neurotrophic factor.
  • The two are described in their source literature as addressing different aspects of stress response, which is the argument for pairing them.

What is not established

  • Any benefit of the pairing over either component alone.
  • Replication of Russian findings under contemporary Western methodology.
  • Safety over extended use.
  • Interaction with psychiatric medicines.

Questions to discuss with a physician

  • Is what I am describing better addressed by established treatment?
  • How should I weigh research conducted outside the FDA framework?
  • What interactions should I worry about with my current medicines?
  • How would we measure whether anything changed?
  • What would make you stop?

This page is educational. Nothing here can be ordered, and nothing here is a prescription or medical advice. Compounded preparations are not FDA-approved. To ask about current availability, visit goal.md/peptides/connect or call or text 314-907-3103.

Medically reviewed by Michael Fitch, MD, MD. Last reviewed 2026-08-15.